Pages that link to "Q40232514"

The following pages link to Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas (Q40232514):

Displaying 46 items.

• Genetics of melanocytic nevi (Q28085036) (← links)
• Benign atypical naevi: diagnostic difficulties and continued controversy (Q33601883) (← links)
• Clinicopathological features and prognosis of patients with de novo versus nevus-associated melanoma in Taiwan (Q33638140) (← links)
• A randomized, double-blind, placebo-controlled phase II clinical trial of lovastatin for various endpoints of melanoma pathobiology (Q34400230) (← links)
• Molecular aspects of melanocytic dysplastic nevi (Q34622005) (← links)
• Diagnostic assessment of two novel proliferation-specific antigens in benign and malignant melanocytic lesions (Q35796469) (← links)
• Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues (Q36109510) (← links)
• Chronic growth stimulation of human adult melanocytes by inflammatory mediators in vitro: implications for nevus formation and initial steps in melanocyte oncogenesis (Q36131576) (← links)
• The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects (Q36762792) (← links)
• Proposed alternative terminology and subclassification of so called "dysplastic naevi". (Q37201363) (← links)
• Histologically challenging melanocytic tumors referred to a tertiary care pigmented lesion clinic (Q38004233) (← links)
• Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression (Q38429857) (← links)
• Melanocytic nevi and melanoma: unraveling a complex relationship (Q38730348) (← links)
• Absence of distinguishing senescence traits in human melanocytic nevi (Q39362670) (← links)
• Dysplastic nevi. Their significance and management. (Q39644954) (← links)
• Melanocytic precursors of cutaneous melanoma. Estimated risks and guidelines for management. (Q39726048) (← links)
• Sun and malignant melanoma. (Q40189993) (← links)
• Precursors to melanoma and their mimics: nevi of special sites (Q40354356) (← links)
• DNA repair synthesis following irradiation with 254-nm and 312-nm ultraviolet light is not diminished in fibroblasts from patients with dysplastic nevus syndrome (Q41392622) (← links)
• Skin Types in Dysplastic Nevus Syndrome (Q41439538) (← links)
• The dysplastic melanocytic nevus: a prevalent lesion that correlates poorly with clinical phenotype (Q43903155) (← links)
• The efficacy of histopathological criteria required for diagnosing dysplastic naevi (Q44060831) (← links)
• The ultrastructure of dysplastic naevi: comparison with superficial spreading melanoma and common naevocellular naevi (Q44879067) (← links)
• Activation of the melanocyte system by ultraviolet radiation and cell transformation (Q45157479) (← links)
• Nuclear and cytoplasmic features in the diagnosis of Clark's nevi. (Q46502457) (← links)
• Precursors of malignant melanoma. Problems in computing the risk of malignant melanoma arising in dysplastic and congenital nevocytic nevi. (Q52673542) (← links)
• Age distribution and histologic patterns of dysplastic nevi. (Q53732573) (← links)
• Histopathologic diagnosis of dysplastic nevi: Concordance among pathologists convened by the world health organization melanoma programme (Q67758686) (← links)
• Fibroblasts derived from patients with dysplastic nevus syndrome are not more sensitive towards 254-nm and 312-nm ultraviolet light than fibroblasts from normal donors (Q68202392) (← links)
• Melanoma cell heterogeneity. A study of two monoclonal antibodies compared with s-100 protein in paraffin sections (Q68343808) (← links)
• The relationship between melanocytic nevi and malignant melanoma (Q68390224) (← links)
• Residual dysplastic and other nevi in superficial spreading melanoma. Clinical correlations and association with sun damage (Q68408724) (← links)
• Positive Reactivity of Dysplastic Melanocytes with a Monoclonal Antibody Against Melanoma Melanosomes, MoAb HMSA-2 (Q68489124) (← links)
• Dysplastic nevus syndrome. Familial and sporadic precursors of cutaneous melanoma (Q69786265) (← links)
• The management of patients with dysplastic and congenital nevi (Q69786276) (← links)
• Nevomelanocytic proliferations in association with cutaneous malignant melanoma: a multivariate analysis (Q69786799) (← links)
• Diagnosis of the dysplastic nevus in different populations (Q70031903) (← links)
• Malignant melanoma--its precursors and its topography of proliferation. DNA-Feulgen-cytophotometry and mitosis index (Q70287006) (← links)
• Melanoma in situ (MIS) adjacent to an invasive nodular melanoma ("SSM/NM") and its metastases--DNA-cytophotometry, mitotic index, and anisokaryosis (Q70352303) (← links)
• Family study of atypical nevi with investigation of heparin sulfate proteoglycan (Q71820529) (← links)
• Dysplastic nevi revisited (Q72404211) (← links)
• Allelic deletion at chromosome 9p21(p16) and 17p13(p53) in microdissected sporadic dysplastic nevus (Q74268765) (← links)
• Intervention strategy to prevent lethal cutaneous melanoma: Use of dermatologic photography to aid surveillance of high-risk persons (Q77093818) (← links)
• Enhanced expression of Ki-67, topoisomerase IIalpha, PCNA, p53 and p21WAF1/Cip1 reflecting proliferation and repair activity in UV-irradiated melanocytic nevi (Q77726721) (← links)
• Practical advice regarding problematic pigmented lesions (Q84389298) (← links)
• Is There More Than One Road to Nevus-Associated Melanoma? (Q94503452) (← links)